Revenue: The sum of all revenue fields included for a company's operating activities.
Harmony Biosciences Holdings, Inc. (HRMY) had Revenue of $268.92M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
|
Revenue |
$268.92M |
$48.20M |
|
$80.69M |
|
$188.23M |
|
$214.72M |
|
$54.20M |
|
$5.05M |
|
$59.25M |
|
$59.25M |
|
$48.20M |
|
$48.20M |
|
$48.20M |
|
$48.20M |
|
$54.20M |
|
-- |
|
58.41M |
|
59.68M |
|
$0.83 |
|
$0.81 |
|
| Balance Sheet Financials | |
$934.83M |
|
-- |
|
$543.41M |
|
$1.48B |
|
$271.54M |
|
$129.10M |
|
$134.47M |
|
$406.01M |
|
$1.07B |
|
$1.00B |
|
$1.07B |
|
58.72M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|